Evoke Pharma (EVOK.US) stock price is influenced by various factors: FDA Decisions: Regulatory approvals (or rejections) for their drug, Gimoti, directly impact investor sentiment and the stock's valuation.

Sales Performance: Gimoti's sales figures, revenue growth, and market penetration are critical indicators of the company's financial health and future prospects.

Clinical Trial Results: Results from any ongoing or future clinical trials can significantly affect the stock price, especially if they suggest new applications or improved efficacy of Gimoti.

Competition: The presence of competing drugs or therapies in the gastroparesis market can influence Gimoti's market share and Evoke Pharma's profitability.

Market Conditions: General market trends, economic conditions, and investor sentiment towards the pharmaceutical industry as a whole can indirectly impact EVOK.US.

Company News: Announcements regarding partnerships, acquisitions, financial results, and other corporate developments can influence investor confidence.

Analyst Ratings: Recommendations and price targets from financial analysts can influence buying or selling pressure on the stock.

Debt Levels: Evoke Pharma's level of debt and its ability to manage its financial obligations can affect investor perception of the company's stability.

Manufacturing: Production disruptions or challenges in scaling up manufacturing of Gimoti could negatively affect the stock price.

Intellectual Property: The strength and duration of Evoke Pharma's patents related to Gimoti are crucial for protecting its market exclusivity and long-term revenue potential.